Atrial fibrillation (AF) is our most common heart rhythm disorder -- affecting millions of people yearly, including >10% by age 80. AF can cause stroke, heart failure, and even death (with a societal cost exceeding $7 billion annually). Fortunately, the past two decades have brought major advances in identification and treatment, allowing for earlier detection, reduction of risk, and therapies that dramatically improve outcomes. This engaging and informative program is ideal for older adults interested in understanding AF, its warning signs, how to detect it, and how to manage it. Its messages can be lifesaving. Whether for yourself or a loved one, join us to learn how modern medicine is transforming care and improving quality of life for those affected by atrial fibrillation. This program is being presented with limited enrollment to foster discussion.
Dr. James A. Reiffel is Professor Emeritus of Medicine at Columbia University Vagelos College of Physicians and Surgeons and a longtime expert in cardiology, electrophysiology, and cardiac pharmacology with over four decades of clinical, teaching, and research experience. He has authored over 500 medical publications, served in advisory roles for the FDA and medical companies, led major clinical trials, and currently serves on the boards of the Loggerhead Marinelife Center and Sarah P. Duke Gardens.
